Edgestream Partners, L.P. Laboratory Corp Of America Holdings Transaction History

Edgestream Partners, L.P.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$209.01 - $232.56 $4.3 Million - $4.78 Million	20,567 New	20,567 $4.49 Million
Q1 2021 May 06, 2021	SELL	$204.88 - $255.03 $7 Million - $8.71 Million	-34,153 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$186.91 - $214.42 $6.38 Million - $7.32 Million	34,153 New	34,153 $6.95 Million
Q1 2019 May 15, 2019	SELL	$123.7 - $156.3 $1.15 Million - $1.46 Million	-9,319 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$120.82 - $174.09 $167,818 - $241,811	-1,389 Reduced 12.97%	9,319 $1.18 Million
Q3 2018 Nov 07, 2018	BUY	$167.67 - $188.27 $1.8 Million - $2.02 Million	10,708 New	10,708 $1.86 Million
Q2 2018 Aug 09, 2018	SELL	$160.33 - $189.41 $200,572 - $236,951	-1,251 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$161.53 - $178.11 $73,657 - $81,218	-456 Reduced 26.71%	1,251 $202,000
Q4 2017 Feb 09, 2018	SELL	$147.99 - $163.95 $105,664 - $117,060	-714 Reduced 29.49%	1,707 $272,000
Q3 2017 Oct 30, 2017	BUY	$149.47 - $160.56 $361,866 - $388,715	2,421	2,421 $365,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $21.5B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Edgestream Partners, L.P., based on Form 13F filings with the SEC.

Stay updated on Edgestream Partners, L.P. with notifications on news.